{"id": "1356961164991881219", "creation": 1612359727.0, "user_id": "2563262155", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}, "text": "Safety and efficacy of an #rAd26 &amp; #rAd5 vector-based #heterologous prime-boost #COVID19 #vaccine: an interim analysis of a randomised controlled phase 3 trial in Rusia. #TheLancet #Sputnik #SARSCoV2 #BreakingNews \n\nhttps://t.co/DLjFC2TB4L", "first_save": 1634559108.199414, "hashtags": ["#RAD26", "#RAD5", "#HETEROLOGOUS", "#COVID19", "#VACCINE", "#THELANCET", "#SPUTNIK", "#SARSCOV2", "#BREAKINGNEWS"]}